SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid Tumors
Cell Origin Biotech (Hangzhou) Co., Ltd.
Cell Origin Biotech (Hangzhou) Co., Ltd.
Hospital del Mar
Chang Gung Memorial Hospital
Silesian Centre for Heart Diseases
Rigshospitalet, Denmark
Soonchunhyang University Hospital
Canada Royal Enoch Phytomedicine Co., Ltd.
Selcuk University
Gynaecologisch Oncologisch Centrum Zuid
Sixth Affiliated Hospital, Sun Yat-sen University